PlasmaKinetic (PK) Button Vaporization Electrode for Treatment of Bladder Tumors



Status:Completed
Conditions:Cancer, Cancer, Bladder Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - 89
Updated:12/10/2017
Start Date:September 2012
End Date:March 28, 2017

Use our guide to learn which trials are right for you!

PK Button Vaporization Electrode for Treatment of Bladder Tumors

The purpose of this study is to compare the use of two types of equipment during
transurethral resection of bladder tumors (TURBT). The two types of surgical devices are: the
monopolar loop electrocautery and the PlasmaKinetic (PK) Button Vaporization Electrode. These
two devices do the same task but differ in the way they create electric current when removing
cancerous tissue. The investigators hope to examine and compare the uses of these two
surgical devices to see if any advantages do exist or whether they actually are similar. The
goal of the study is to prove similarity in outcomes between the two techniques and analyze
the outcomes resulting from each case.

This study will study the medical intervention used when bladder cancer patients present with
a new or recurrent bladder tumor. Currently when patients report these tumors, they undergo a
standard practice called transurethral resection of the bladder tumor (TURBT) in order to
determine the stage of the cancer. This intervention, accomplished by looking through the
urethra using an endoscope, is both diagnostic and potentially therapeutic. An adequately
performed TURBT will provide the pathologist with enough tissue to provide tumor grade and
stage information. Currently, TURBT is done using equipment called monopolar electrocautery
which is in the form a 90-degree loop electrode. Although usually safe and sufficient, this
technique can create technical challenges because it can be difficult to position the loop
electrode in a dynamically changing cylindrical space (the bladder). Specifically, especially
with larger bladder tumors, intraoperative bleeding can obscure visualization and result in
incomplete tumor resection as well as inadequate sampling of the layers of the bladder needed
to establish tumor stage. Furthermore, monopolar current can result in stimulation of a nerve
(the obturator nerve) during resection of wall tumors, resulting in violent movement of the
leg which can cause a potential bladder tear as well as possible (iliac) vessel injury.

Conversely, a technique using bipolar energy, which has been available for many years, has
been readily adopted for the surgical treatment of benign prostatic enlargement. The
advantages of a bipolar electrical current include the direct return of electrical current to
the loop rather than to a grounding pad placed on the patient's skin. This has the
theoretical value of limiting the diffusion of electrical current, and therefore heat, to the
surrounding tissue. A further refinement on bipolar energy has been the recent introduction
of a piece of equipment called the PlasmaKinetic (PK) Button Vaporization electrode, which is
currently approved by the Food and Drug Administration (FDA) for this indication. Coupling
bipolar energy into the Button electrode would not only harness the benefits of less thermal
spread but also would obviate the geometric challenges associated with loop electrodes during
resection of bladder tumors. Procedural advantages would potentially include minimal
bleeding, good visualization, and a reduction in the occurrence of the obturator reflex and
concomitant bladder perforation.

This study is a randomized double-arm trial examining the results of both techniques for
bladder cancer TURBT procedures with a minimum of 120 patients at Emory. The purpose of this
study is to measure the procedural (intraoperative), short term, as clinically indicated (4-6
weeks), and long-term (3 months) outcomes of TURBT using the PK Button when compared to
traditional monopolar loop electrocautery. The goal of the study is to prove equivalence in
outcomes between the two techniques.

Inclusion Criteria:

- Patients with cystoscopically detected bladder tumors requiring TURBT

- Patients with bladder tumors which are endoscopically resectable by surgeon's judgment
with only one trip into the operating room.

Exclusion Criteria:

- Patients with clinical evidence of locally advanced, nodal, or metastatic bladder
cancer

- Patients with hydronephrosis secondary to bladder cancer

- Patients with diffuse tumor throughout bladder that is deemed unresectable by surgeon
We found this trial at
1
site
Atlanta, Georgia 30322
Phone: 404-778-4823
?
mi
from
Atlanta, GA
Click here to add this to my saved trials